Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“We are happy to announce that our project ‘PhenoPDAC‘ has been selected for the 2025 Proof-of-Concept grant from FRAP Network – Pancreatic Cancer.
The project is led at the CRCM – Cancer Research Center of Marseille in close interaction with the Institut Paoli-Calmettes, and aims to establish a proof-of-concept pipeline combining patient-derived organoid-CAF co-cultures, high-content live imaging and transcriptomic analyses, to better capture mechanisms of drug response and resistance in pancreatic cancer.
This work is carried out in close collaboration with Rémy Nicolle and his team at the CRI – Centre for Research on Inflammation– INSERM U1149, who bring strong expertise in integrative bioinformatics, image-omics and predictive modeling, building on their previous contributions to the field.
We thank FRAP for their confidence and support, and for their structuring role in fostering high-quality collaborative research, enabling the development of shared tools and approaches for the pancreatic cancer research community.”
More posts featuring Nelson Dusetti.